G D Dimitriadis
Overview
Explore the profile of G D Dimitriadis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Triantafyllou K, Kourikou A, Gazouli M, Karamanolis G, Dimitriadis G
Neurogastroenterol Motil
. 2016 Jul;
29(1).
PMID: 27430937
Background: Functional dyspepsia (FD) susceptibility might be influenced by polymorphisms of genes related to inflammation (CD14, macrophage migration inhibitory factor [MIF]), motor (GNB3), and sensory dysfunction (GNB3, TRPV1). We examined...
2.
Raptis A, Bacharaki D, Mazioti M, Marathias K, Markakis K, Raptis S, et al.
Exp Clin Endocrinol Diabetes
. 2012 Mar;
120(7):416-9.
PMID: 22441720
Therapy with either angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARB) or thiazolidinediones (TZD) is associated with dose-dependent decrements in hematocrit and hemoglobin levels. We aimed to investigate the...
3.
Raptis S, Dimitriadis G
Exp Clin Endocrinol Diabetes
. 2001 Jul;
109 Suppl 2:S265-87.
PMID: 11460577
In this review we present the agents that are in use in the treatment of type 2 diabetes. Sulfonylureas of the 1st and 2nd generation increase insulin secretion but can...
4.
Dimitriadis G, Raptis S
Exp Clin Endocrinol Diabetes
. 2001 Jul;
109 Suppl 2:S225-39.
PMID: 11460573
The elevated plasma glucose levels in hyperthyroidism may be explained by increased rates of endogenous glucose production, due mainly to increased gluconeogenesis. The rates of insulin-stimulated glucose disposal in peripheral...
5.
Parry-Billings M, Dimitriadis G, Leighton B, Dunger D, Newsholme E
Horm Metab Res
. 1993 Jun;
25(6):292-3.
PMID: 8344642
Human growth hormone administration to the rat for 3 or 10 days increased the concentrations of glutamine in both skeletal muscle and plasma and the rate of glutamine release was...
6.
Dimitriadis G, Richards S, Parry-Billings M, Leighton B, Newsholme E, Challiss R
Biochem J
. 1991 Sep;
278 ( Pt 2):587-93.
PMID: 1680321
1. The actions of the beta-adrenoceptor agonist isoprenaline on glucose and glycogen metabolism, in the presence of various concentrations of insulin, were investigated in isolated soleus muscle preparations taken from...
7.
Parry-Billings M, Leighton B, Dimitriadis G, Bond J, Newsholme E
Biochem Soc Trans
. 1991 Apr;
19(2):130S.
PMID: 1889531
No abstract available.
8.
Parry-Billings M, Leighton B, Dimitriadis G, Curi R, Bond J, Bevan S, et al.
Int J Biochem
. 1991 Jan;
23(9):933-7.
PMID: 1773899
1. The effects of tumour bearing on glutamine metabolism in rat skeletal muscle were examined using the Walker 256 carcinosarcoma. 2. There was a rapid and marked decrease in skeletal...
9.
Parry-Billings M, Dimitriadis G, Leighton B, Bond J, Bevan S, Opara E, et al.
Biochem J
. 1990 Dec;
272(2):319-22.
PMID: 2268261
1. The effects of hyperthyroidism and hypothyroidism on the concentrations of glutamine and other amino acids in the muscle and plasma and on the rates of glutamine and alanine release...
10.
Parry-Billings M, Leighton B, Dimitriadis G, Bond J, Newsholme E
Biochem Pharmacol
. 1990 Sep;
40(5):1145-8.
PMID: 2390110
The effects of physiological and pathological concentrations of glucocorticoids were investigated using the glucocorticoid antagonist RU486 and the synthetic glucocorticoid dexamethasone, respectively. The effects of these treatments on the concentrations...